{"log_id": 2937140352983502335, "direction": 0, "words_result_num": 37, "words_result": [{"probability": {"variance": 0.022507, "average": 0.932566, "min": 0.488638}, "location": {"width": 329, "top": 137, "height": 32, "left": 258}, "words": "患者应在有经验的医生指导下服用本苗"}, {"probability": {"variance": 0.006238, "average": 0.961235, "min": 0.654747}, "location": {"width": 722, "top": 170, "height": 39, "left": 254}, "words": "推荐剂量:成人和16岁以上青少年口服本品,每天一次,每次0.5mg。拉米夫定治疗"}, {"probability": {"variance": 0.014563, "average": 0.9363, "min": 0.496539}, "location": {"width": 716, "top": 209, "height": 41, "left": 209}, "words": "时发生病毒症或出现拉米夫定耐药突变的思者为每天一次,每次1mg(0.5mng两片"}, {"probability": {"variance": 0.010287, "average": 0.957976, "min": 0.571924}, "location": {"width": 366, "top": 255, "height": 34, "left": 253}, "words": "本品应空腹服用(餐前或餐后至少2小时)"}, {"probability": {"variance": 0.029492, "average": 0.910396, "min": 0.567019}, "location": {"width": 99, "top": 331, "height": 24, "left": 207}, "words": "肾功能不企"}, {"probability": {"variance": 0.001505, "average": 0.98343, "min": 0.800305}, "location": {"width": 725, "top": 356, "height": 40, "left": 249}, "words": "在肾功能不全的患者中,恩替卡韦的表观口服清除率随肌酐清除率的降低而降低(参"}, {"probability": {"variance": 0.015836, "average": 0.934899, "min": 0.407705}, "location": {"width": 767, "top": 396, "height": 40, "left": 207}, "words": "见药代动力学:特殊人群)肌酐消除率<50mL/分钟的患者(包括接受血液透析或CAPD治疗"}, {"probability": {"variance": 0.01807, "average": 0.929889, "min": 0.478791}, "location": {"width": 293, "top": 444, "height": 31, "left": 203}, "words": "的患者)应调整用药剂量。见表7"}, {"probability": {"variance": 0.017591, "average": 0.934359, "min": 0.472995}, "location": {"width": 346, "top": 509, "height": 32, "left": 202}, "words": "表7:肾功能不全患者思替卡韦推荐剂"}, {"probability": {"variance": 0.010325, "average": 0.940534, "min": 0.610511}, "location": {"width": 172, "top": 557, "height": 24, "left": 236}, "words": "肌酐清除率(mL/min)"}, {"probability": {"variance": 0.001039, "average": 0.978879, "min": 0.913653}, "location": {"width": 148, "top": 551, "height": 24, "left": 503}, "words": "通常剂量(0.5mg"}, {"probability": {"variance": 0.008267, "average": 0.9439, "min": 0.702869}, "location": {"width": 215, "top": 545, "height": 25, "left": 737}, "words": "拉米夫定治疗失效(1mg"}, {"probability": {"variance": 0.007978, "average": 0.934567, "min": 0.808268}, "location": {"width": 42, "top": 595, "height": 23, "left": 300}, "words": "≥50"}, {"probability": {"variance": 0.01343, "average": 0.941724, "min": 0.65034}, "location": {"width": 204, "top": 590, "height": 25, "left": 480}, "words": "每日一次、每次0.5mg"}, {"probability": {"variance": 0.014233, "average": 0.937629, "min": 0.654612}, "location": {"width": 185, "top": 584, "height": 26, "left": 752}, "words": "每日一次,每次mg"}, {"probability": {"variance": 0.010714, "average": 0.945292, "min": 0.714104}, "location": {"width": 86, "top": 635, "height": 24, "left": 277}, "words": "30到<50"}, {"probability": {"variance": 0.022968, "average": 0.924659, "min": 0.422908}, "location": {"width": 474, "top": 624, "height": 30, "left": 476}, "words": "每日一次,每次0.25m每日一次,每次0.5m8"}, {"probability": {"variance": 0.000187, "average": 0.98573, "min": 0.957648}, "location": {"width": 84, "top": 675, "height": 23, "left": 278}, "words": "10到<30"}, {"probability": {"variance": 0.033192, "average": 0.907564, "min": 0.368028}, "location": {"width": 475, "top": 663, "height": 31, "left": 475}, "words": "每日一次,每次0.15m每日一次:每次0.3"}, {"probability": {"variance": 0.013852, "average": 0.933949, "min": 0.612574}, "location": {"width": 167, "top": 713, "height": 27, "left": 235}, "words": "血液透析*或CAPD"}, {"probability": {"variance": 0.011111, "average": 0.952391, "min": 0.597364}, "location": {"width": 474, "top": 702, "height": 31, "left": 475}, "words": "每日一次,每次0.05mg每日一次,每次0.1"}, {"probability": {"variance": 0.043175, "average": 0.911968, "min": 0.364344}, "location": {"width": 150, "top": 765, "height": 26, "left": 196}, "words": "血液透析后用药"}, {"probability": {"variance": 2e-06, "average": 0.998926, "min": 0.995928}, "location": {"width": 100, "top": 836, "height": 25, "left": 194}, "words": "肝功能不全"}, {"probability": {"variance": 0.001533, "average": 0.981625, "min": 0.874857}, "location": {"width": 295, "top": 874, "height": 32, "left": 236}, "words": "肝功能不全患者无需调整用药剂量"}, {"probability": {"variance": 2e-06, "average": 0.998607, "min": 0.995702}, "location": {"width": 100, "top": 942, "height": 25, "left": 194}, "words": "治疗的时间"}, {"probability": {"variance": 0.001199, "average": 0.984711, "min": 0.84885}, "location": {"width": 738, "top": 965, "height": 43, "left": 232}, "words": "关于本品的最佳治疗时间,以及与长期的治疗结果的关系,如肝硬化、肝等,目前尚"}, {"probability": {"variance": 0.001152, "average": 0.963596, "min": 0.917739}, "location": {"width": 57, "top": 1022, "height": 24, "left": 193}, "words": "未明了"}, {"probability": {"variance": 0.021993, "average": 0.819509, "min": 0.67121}, "location": {"width": 54, "top": 1087, "height": 23, "left": 199}, "words": "告]"}, {"probability": {"variance": 0.006493, "average": 0.961309, "min": 0.718333}, "location": {"width": 239, "top": 1123, "height": 29, "left": 188}, "words": "1.停止治疗后的病情加重"}, {"probability": {"variance": 0.022241, "average": 0.946992, "min": 0.367185}, "location": {"width": 726, "top": 1149, "height": 43, "left": 241}, "words": "当慢性乙肝病人停止抗乙肝治疗后,包括恩替卡韦在内经发现有重度急性肝炎发"}, {"probability": {"variance": 0.015247, "average": 0.951414, "min": 0.465005}, "location": {"width": 777, "top": 1189, "height": 44, "left": 188}, "words": "作的报道,对那些停止抗乙肝治疗的病人的肝功能情况应从临床利实验室检查等方面严密监"}, {"probability": {"variance": 0.037695, "average": 0.897247, "min": 0.436234}, "location": {"width": 545, "top": 1231, "height": 41, "left": 187}, "words": "察,并且至少随访数月如必要,可重新恢复抗乙肝病进的治疗"}, {"probability": {"variance": 0.023209, "average": 0.930335, "min": 0.358854}, "location": {"width": 733, "top": 1266, "height": 44, "left": 234}, "words": "在Ⅲ期临床试验中,有一组病人在第52周达案所规定的应被允许停药,肝"}, {"probability": {"variance": 0.01858, "average": 0.958456, "min": 0.355281}, "location": {"width": 778, "top": 1303, "height": 45, "left": 188}, "words": "炎急性发作或ALT暴发被定义为:ALT大于10倍的正常上限和大于2倍的基线水平如"}, {"probability": {"variance": 0.020021, "average": 0.935454, "min": 0.385939}, "location": {"width": 779, "top": 1339, "height": 47, "left": 186}, "words": "表8所示:核苷类药物初治病人在停药后发生ALT暴发的比例由拉米夫定失效病人的达"}, {"probability": {"variance": 0.016333, "average": 0.952839, "min": 0.420049}, "location": {"width": 778, "top": 1377, "height": 47, "left": 187}, "words": "到停药标准而停药的比例较小,故其在停药后发生AT暴发的比例尚未确定如果本品在来"}, {"probability": {"variance": 0.001146, "average": 0.974252, "min": 0.891567}, "location": {"width": 533, "top": 1422, "height": 40, "left": 185}, "words": "达到停药标准而予停药时,则发生停药后ALT暴发的概率增加"}], "language": 3}